Spondyloarthritis

EULAR/PReS Standards for Transitional Care of Juvenile-Onset Rheumatic Diseases

Panel advises that up to 50% of young patients with juvenile-onset rheumatic diseases fail to successfully transition to adult rheumatology services.

Clinician Roundtable: Effective Management of Noninfectious Uveitis

Autoimmune uveitis is usually a diagnosis of exclusion. Part of the challenge of effective management of noninfectious uveitis is that it is not really a ...

Video Review: Differentiating Septic and Reactive Arthritis

Seronegative spondyloarthropathies associated with human leukocyte antigen (HLA) B27 antigens can manifest as an acute inflamed joint and must be differentiated from septic arthritis.

Lead Investigator Discusses Phase 3 Trial of IL-17A Inhibitor in PsA

Philip Mease, MD, clinical professor, University of Washington School of Medicine, Seattle, discusses the treatment of psoriatic arthritis (PsA) by inhibiting interleukin (IL)-17A with the ...

When Should Rheumatologists Refer Patients for Evaluation by an Orthopedic Surgeon?

Michael M. Alexiades, MD, met with Rheumatology Advisor to discuss the timely referral of patients with inflammatory arthritides who may be candidates for operative intervention.

Evaluation of the Pediatric Patient With Joint Pain and Swelling

Watch a video providing a comprehensive review of the distinguishing factors between the presentation of septic arthritis and Lyme arthritis.

VIDEO: Discussing the Use of Biosimilars for Rheumatic Disease

Discussion of the recent introduction of biosimilar agents into the treatment armamentarium for rheumatic disease.

Delayed Recognition of Spondyloarthritis: Diagnostic Challenges & Opportunities

Delayed diagnosis is associated with worse outcomes and poor treatment responses in patients with spondyloarthritis. Andrew Vreede, MD, University of Wisconsin School of Medicine and ...

Looking Beyond Corticosteroids to Treat Noninfectious Uveitis

The recent US Food and Drug Administration (FDA) approval of adalimumab (Humira®, AbbVie) for the treatment of noninfectious intermediate, posterior, and pan-uveitis is the first ...

Looking Beyond Traditional CV Risk Factors to Predict CV Events in PsA

In addition to traditional cardiovascular risk factors, increased PsA disease activity also appears to increase cardiovascular risk.

Latest News

Ankylosing Spondylitis Systemic Therapy Associated With Improved Visual Acuity in Uveitis

Systemic Therapy Associated With Improved Visual Acuity in Uveitis

At seven-year follow-up, visual acuity was better with systemic therapy than with intravitreous fluocinolone acetonide implants.

Ankylosing Spondylitis MTX  Adalimumab Effective in JIA-Associated Uveitis

MTX + Adalimumab Effective in JIA-Associated Uveitis

In children with active juvenile idiopathic arthritis, the treatment combination controls eye inflammation.

Spondyloarthritis Risk for Endocrine Comorbidities Increased in Psoriatic Arthritis

Risk for Endocrine Comorbidities Increased in Psoriatic Arthritis

Researchers evaluated the prevalence of several endocrine disorders in patients with psoriatic arthritis.

Spondyloarthritis GRAPPA-OMERACT: PsA Outcomes Measures Updated for Greater Inclusion of Patient Concerns

GRAPPA-OMERACT: PsA Outcomes Measures Updated for Greater Inclusion of Patient Concerns

The domains for outcome measurement in clinical trials of psoriatic arthritis were updated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis and endorsed by Outcome Measures in Rheumatology.

Spondyloarthritis GRAPPA-OMERACT: Updated PsA Outcomes Measures Offer Greater Inclusion of Patient Concerns

GRAPPA-OMERACT: Updated PsA Outcomes Measures Offer Greater Inclusion of Patient Concerns

The domains for outcome measurement in clinical trials of psoriatic arthritis were updated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis and endorsed by Outcome Measures in Rheumatology.

Psoriatic Arthritis Uveitis Risk Higher Among Patients With Psoriasis

Uveitis Risk Higher Among Patients With Psoriasis

Patients with severe psoriasis and those with mild psoriasis and concomitant psoriatic arthritis have an increased risk of uveitis.

Psoriatic Arthritis First Line Biologic for Psoriasis Influenced By Certain Factors

First Line Biologic for Psoriasis Influenced By Certain Factors

Psoriatic arthritis, patient weight, registration country and more influence first-line biologic treatment selection for patients with psoriasis.

Psoriatic Arthritis Women Have Lower Psoriasis Area and Severity Index Scores Than Men

Women Have Lower Psoriasis Area and Severity Index Scores Than Men

Women were found to have a lower median of scores in the Psoriasis Area and Severity Index than men.

Ankylosing Spondylitis Etanercept May Increase Risk of Anterior Uveitis in Ankylosing Spondylitis

Etanercept May Increase Risk of Anterior Uveitis in Ankylosing Spondylitis

Researchers examined whether different TNF inhibitors were associated with different rates of anterior uveitis in patients with ankylosing spondylitis undergoing treatment with adalimumab, etanercept, or infliximab.

Psoriatic Arthritis Psoriatic Arthritis Development Predicted by Musculoskeletal Symptoms

Psoriatic Arthritis Development Predicted by Musculoskeletal Symptoms

Prospective cohort study of patients with psoriasis who were assessed annually to examine for development of clinical psoriatic arthritis.

Sign Up for Free e-newsletters